Transcatheter aortic valve implantation: Watch out for the leak, irrespective of aortic valve disease type.
Postprocedural aortic regurgitation (PAR) after transcatheter aortic valve implantation (TAVI) is associated with a worst clinical outcome. The presence of chronic aortic regurgitation in TAVI candidates increases PAR risk but not overall survival. Future valve prototypes will likely reduce the degree and frequency of this complication.
Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular De Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina.
Jorge A
JA
Belardi
Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular De Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina.
Mariano
M
Albertal
D001021:Aortic Valve; D001022:Aortic Valve Insufficiency; D001024:Aortic Valve Stenosis / Q000601:surgery*; D006328:Cardiac Catheterization; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D065467:Transcatheter Aortic Valve Replacement; D016896:Treatment Outcome